Cytosorbents Corp Share Price OTC Bulletin Board
Equities
CTSO
US23283X1072
Advanced Medical Equipment & Technology
Sales 2024 * | 39.52M 3.3B | Sales 2025 * | 46.83M 3.91B | Capitalization | 48.22M 4.03B |
---|---|---|---|---|---|
Net income 2024 * | -20M -1.67B | Net income 2025 * | -9M -752M | EV / Sales 2024 * | 1.22 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.03 x |
P/E ratio 2024 * |
-2.42
x | P/E ratio 2025 * |
-4.93
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.8% |
Latest transcript on Cytosorbents Corp
Managers | Title | Age | Since |
---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 53 | 24/08/24 |
Vincent Capponi
PSD | President | 66 | 25/02/25 |
Kathleen Bloch
DFI | Director of Finance/CFO | 69 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bator
CHM | Chairman | 60 | 14/15/14 |
Phillip Chan
CEO | Chief Executive Officer | 53 | 24/08/24 |
Edward Jones
BRD | Director/Board Member | 75 | 01/07/01 |
1st Jan change | Capi. | |
---|---|---|
+9.48% | 222B | |
+13.72% | 195B | |
+23.79% | 148B | |
+33.39% | 113B | |
+4.41% | 66.45B | |
+3.16% | 50.03B | |
-4.35% | 38.8B | |
-1.27% | 34.85B | |
+22.61% | 30.98B |